TO THE EDITOR: The unrivaled sensitivity of PET for imaging molecular interactions remains largely unexploited in oncology. At present, PET mainly uses 18F-labeled FDG PET to diagnose and stage cancer by imaging primary and macroscopic metastatic deposits. We wish to draw attention to the
No takes yet. Share an insight, caveat, or question.
Price et al. (2014) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: